Castagna A - Search Results

1

Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score.

Tiseo G, Margalit I, Ripa M, Borghi V, Green H, Prendki V, Riccardi N, Dishon Y, Perego GB, Grembiale A, Galli L, Tinelli M, Castagna A, Mussini C, Yahav D, Paul M, Falcone M; ESCMID Study Group for Infections in the Elderly (ESGIE). Tiseo G, et al. Among authors: castagna a. Clin Microbiol Infect. 2023 Mar;29(3):379-385. doi: 10.1016/j.cmi.2022.09.019. Epub 2022 Sep 30. Clin Microbiol Infect. 2023. PMID: 36191845 Free PMC article.

2

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.

Mussini C, Manzardo C, Johnson M, Monforte Ad, Uberti-Foppa C, Antinori A, Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miró JM, Sabin C; Late Presenter Investigators. Mussini C, et al. AIDS. 2008 Nov 30;22(18):2461-9. doi: 10.1097/QAD.0b013e328314b5f1. AIDS. 2008. PMID: 19005269

3

Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients.

Spagnuolo V, Gianotti N, Seminari E, Galli L, Fusetti G, Salpietro S, Lazzarin A, Castagna A. Spagnuolo V, et al. Among authors: castagna a. J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):192-5. doi: 10.1097/QAI.0b013e31819367fc. J Acquir Immune Defic Syndr. 2009. PMID: 19131889

4

Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failure.

Cossarini F, Galli L, Sagnelli C, Gianotti N, Hasson H, Clementi M, Soria A, Salpietro S, Lazzarin A, Castagna A. Cossarini F, et al. Among authors: castagna a. J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):179-84. doi: 10.1097/QAI.0b013e3181a56f46. J Acquir Immune Defic Syndr. 2009. PMID: 19352200

5

Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group. d'Arminio Monforte A, et al. Among authors: castagna a. Clin Infect Dis. 2009 Aug 15;49(4):612-22. doi: 10.1086/603557. Clin Infect Dis. 2009. PMID: 19591597

6

Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption.

Mussini C, Touloumi G, Bakoyannis G, Sabin C, Castagna A, Sighinolfi L, Erikson LE, Bratt G, Borghi V, Lazzarin A, Cossarizza A, Esposito R. Mussini C, et al. Among authors: castagna a. J Acquir Immune Defic Syndr. 2009 Dec;52(5):588-94. doi: 10.1097/qai.0b013e3181b9e94d. J Acquir Immune Defic Syndr. 2009. PMID: 19950432

7

Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial.

Soria A, Danise A, Galli L, Tiberi S, Seminari E, Cossarini F, Bigoloni A, Marcotullio S, Lazzarin A, Castagna A. Soria A, et al. Among authors: castagna a. J Clin Virol. 2010 Mar;47(3):253-7. doi: 10.1016/j.jcv.2009.12.007. Epub 2010 Jan 6. J Clin Virol. 2010. PMID: 20056480 Clinical Trial.

8

Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.

Castagna A, Galli L, Torti C, D'Arminio Monforte A, Mussini C, Antinori A, Cozzi-Lepri A, Ladisa N, De Luca A, Seminari E, Gianotti N, Lazzarin A. Castagna A, et al. Antivir Ther. 2010;15(2):165-75. doi: 10.3851/IMP1513. Antivir Ther. 2010. PMID: 20386071 Clinical Trial.

9

Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.

Spagnuolo V, Galli L, Salpietro S, Gianotti N, Guffanti M, Cossarini F, Bigoloni A, Cinque P, Bossolasco S, Travi G, Fumagalli L, Lazzarin A, Castagna A. Spagnuolo V, et al. Among authors: castagna a. Int J Cancer. 2012 Jun 15;130(12):2990-6. doi: 10.1002/ijc.26332. Epub 2011 Aug 30. Int J Cancer. 2012. PMID: 21796633 Free article.

10

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL.

Gianotti N, Galli L, Racca S, Salpietro S, Cossarini F, Spagnuolo V, Barda B, Canducci F, Clementi M, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: castagna a. J Antimicrob Chemother. 2012 Jan;67(1):213-7. doi: 10.1093/jac/dkr422. Epub 2011 Oct 10. J Antimicrob Chemother. 2012. PMID: 21987242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,091 results

Search Page